There was consensus on 76.2% of the statements about the common characteristics of long-term survivors/long-term responders (Table 2), which were: oligometastatic NSCLC, adenocarcinoma subtype, with high PD-L1 expression (≥ 50%), without brain metastases or with tumour with less than 2 locations. The gene discussed is CD274; the disease is neoplasm.